CLINICAL_TRIALS
trial_result
· 2014-02-03
Clinical Trial Update: Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome [Phase 3]
Summary
A Phase 3 trial evaluating botulinum toxin type A for male chronic prostatitis/chronic pelvic pain syndrome was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daniel Stephan Engeler | Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatitis | Phase 3 | Status: TERMINATED